Ingredient Guide
Rutin: Benefits, Dosage, and What the Research Says
A plant-derived flavonoid with documented clinical evidence for vascular support, antioxidant enzyme activity, and capillary integrity.
Written by Jessica Medson
Rutin (rutoside, vitamin P) is a plant-derived flavonoid found in foods such as buckwheat, citrus peel, and onions that is studied for its effects on vascular health, antioxidant enzyme activity, and capillary integrity. A 2023 randomized, double-blind trial in 50 adults with type 2 diabetes found that 1 g of rutin daily for three months significantly improved blood pressure and raised antioxidant enzymes compared with placebo.<sup><a href="#ref-1">1</a></sup> The strongest clinical evidence base centers on semi-synthetic derivatives called oxerutins, which have demonstrated meaningful benefits for chronic venous insufficiency in multiple controlled trials enrolling hundreds of patients.
What Is Rutin?
Rutin -- also called rutoside, quercetin-3-rutinoside, or by the outdated name "vitamin P" -- is a naturally occurring flavonoid glycoside present in a wide range of plant foods. Chemically, it consists of the flavonol quercetin bonded to the disaccharide rutinose (a combination of rhamnose and glucose). Despite the vitamin P nickname, rutin is not a true vitamin; that designation dates to early 20th-century research on capillary permeability and has not been retained in modern nutritional classification.5
Foods particularly rich in rutin include:
- Buckwheat -- one of the most concentrated dietary sources
- Citrus peel and the white pith (albedo) of oranges and grapefruits
- Onions and shallots
- Asparagus
- Green and black tea leaves
- Apples and various berries
Typical dietary intakes from food are far below the doses studied in clinical trials (which range from 500 mg to 2000 mg per day), so supplementation is necessary to reach amounts associated with the observed effects. In traditional herbal medicine, rutin-containing plants have historically been used to strengthen blood vessel walls and reduce capillary fragility -- properties that modern research has investigated in controlled settings.5
How Does Rutin Work?
Rutin's biological activities arise from several interconnected mechanisms that act primarily on blood vessels, inflammatory signaling, and oxidative stress pathways.
Antioxidant activity
Rutin is a potent free-radical scavenger. Its polyphenolic ring structure donates hydrogen atoms to neutralize reactive oxygen species and chelates metal ions that would otherwise catalyze oxidative chain reactions. After oral ingestion, gut bacteria cleave rutin's sugar moiety to release free quercetin, which is absorbed into systemic circulation. A human supplementation study confirmed that 500 mg/day of rutin for six weeks significantly elevated plasma levels of three flavonoid metabolites -- quercetin, kaempferol, and isorhamnetin -- with no adverse changes in blood chemistry or liver function markers.2
Anti-inflammatory pathways
Preclinical research identifies multiple anti-inflammatory targets for rutin, including suppression of NF-kappaB activation and reduction of pro-inflammatory cytokines such as TNF-alpha. In hemodialysis patients, a combination of rutin and vitamin C reduced markers of oxidative stress and lipid peroxidation and produced favorable effects on triglycerides and HDL cholesterol compared with controls.4
Vascular and capillary effects
Rutin and its semi-synthetic oxerutin derivatives appear to stabilize the vascular endothelium, reduce capillary permeability, and improve microcirculatory blood flow. These actions -- supported by multiple controlled trials -- form the mechanistic basis for use in chronic venous insufficiency and capillary fragility.5
Antiplatelet properties
Laboratory studies show rutin inhibits platelet aggregation and prolongs coagulation time, in part through inhibition of protein disulfide isomerase (PDI), a surface enzyme on platelets that activates clotting factors. These properties carry practical implications for drug interactions discussed in the Safety section below.
Bioavailability considerations
Standard rutin has low and variable oral bioavailability due to limited water solubility. Absorption depends significantly on gut bacterial hydrolysis and the composition of an individual's microbiome. Semi-synthetic forms -- hydroxyethylrutosides (oxerutins) -- were developed specifically to improve aqueous solubility and are the forms used in most venous-disorder clinical trials.2 Results from oxerutin trials should not be assumed to transfer directly to standard rutin supplements.
Rutin and Vascular Health
The best-studied clinical application of rutin and its derivatives is chronic venous insufficiency (CVI) -- a condition in which impaired venous return causes leg swelling, pain, skin changes, and reduced quality of life affecting millions of adults. Hydroxyethylrutosides (oxerutins, marketed under names such as Venoruton and Paroven) have been tested in multiple randomized controlled trials.
What the research shows
A randomized, placebo-controlled dose-ranging trial in patients with venous hypertension tested two doses of oxerutins over four weeks. Both active doses significantly reduced capillary filtration rate and leg-symptom scores versus placebo; symptom scores in the higher-dose group (3 g/day) fell from approximately 7.9 to 3.1, compared with no significant change in placebo recipients.8
A larger randomized trial enrolled 212 patients with CVI and compared oxerutins (2 g/day) against diosmin/hesperidin (Daflon 1500 mg/day). The oxerutin group achieved a 46.8% improvement in venous quality-of-life scores versus 15.5% in the comparator group -- a statistically significant difference (P less than 0.05) in favor of oxerutins.10
A separate RCT in 90 patients with severe venous hypertension found that 8 weeks of Venoruton (2 g/day) produced significant reductions in resting skin flux and rate of ankle swelling compared with baseline and versus the diosmin group, in which no significant microcirculatory changes were recorded.6
Long-term data from a five-year registry study found that continuous oxerutin use (1500-2000 mg/day) produced no significant adverse changes in blood parameters, and treated patients showed improvements in HDL cholesterol and microalbuminuria -- effects that were particularly pronounced in diabetic participants.9
Regarding post-thrombotic syndrome (PTS), a 2018 Cochrane systematic review of three small trials totaling 233 participants found no evidence that rutosides were superior to placebo or elastic compression stockings for treating established PTS, and characterized the available evidence as low quality.3
Key caveat: Most of this vascular evidence used semi-synthetic oxerutin derivatives, not standard rutin. Whether unmodified rutin supplements at equivalent doses produce similar results has not been directly evaluated in head-to-head trials.
Antioxidant Activity and Metabolic Support
Beyond vascular applications, rutin has been studied as a broad antioxidant and metabolic support agent in populations with elevated oxidative burden.
What the research shows
A 2023 randomized, double-blind, placebo-controlled trial enrolled 50 adults with type 2 diabetes mellitus (25 per group) who received either 1 g of rutin daily or matching placebo for three months. The rutin group experienced significant reductions in systolic blood pressure, diastolic blood pressure, pulse pressure, mean arterial pressure, and heart rate compared with both baseline and the placebo group. Activity of the antioxidant enzymes superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx) increased significantly in the rutin group but not in placebo controls. The authors also reported improvements in emotional well-being, energy levels, mental health, and general health perception on quality-of-life scales.1
A 2022 randomized controlled trial in 105 hemodialysis patients assigned groups to rutin plus vitamin C, vitamin C alone, or an untreated control for 16 weeks. The rutin plus vitamin C group showed a favorable synergistic effect on triglyceride levels, TNF-alpha, and HDL cholesterol that was not seen with vitamin C alone. A tendency toward greater reduction in the lipid peroxidation marker malondialdehyde was also observed in the combination group.4
An earlier human study in 18 healthy women found that 500 mg/day for six weeks significantly elevated plasma flavonoid concentrations, confirming absorption and metabolism in humans. However, no significant change in overall plasma antioxidant capacity or markers of oxidative DNA or lipid damage was detected in these already-healthy subjects.2 This pattern -- greater measurable benefit in individuals with already-elevated oxidative stress -- is consistent across the evidence base and is an important consideration when setting realistic expectations for healthy users.
Preclinical Neuroprotective Research
A growing body of animal and cell-based research suggests rutin may support neurological health. A 2019 narrative review summarizing preclinical findings noted that rutin's neuroprotective effects appear to be "mainly associated to its antioxidant and anti-inflammatory" properties and traced the research arc from in vitro models through animal studies of cognitive impairment, head trauma, and neurodegeneration.11
What the research shows
Animal models have demonstrated that rutin can attenuate cognitive deficits from cerebral hypoperfusion, reduce neuroinflammation, and protect against neurotoxin-induced cell loss in rodent brain tissue. The proposed mechanisms involve reduction of oxidative damage in neural cells, inhibition of apoptotic signaling cascades, and modulation of cholinergic function.
These findings are Tier C (preclinical only). No human clinical trials have evaluated rutin specifically for neuroprotection or cognitive enhancement to date. These results should not be interpreted as established evidence of benefit in humans, and this remains an area requiring well-designed human studies before meaningful conclusions can be drawn.11
Safety, Side Effects, and Interactions
Rutin and its oxerutin derivatives have been administered in clinical studies at doses up to 2 g/day for periods as long as five years without significant adverse blood parameter changes in most participants, supporting a generally favorable safety profile at studied doses.9 The following considerations are nonetheless important for prospective users.
Reported adverse effects
- Mild gastrointestinal symptoms (nausea, stomach discomfort, diarrhea) are the most commonly reported adverse events at higher doses.
- Headache and flushing have been reported occasionally in clinical trials.
- At doses studied in trials (500-2000 mg/day), serious adverse events have not been reported at a frequency different from placebo.
Drug interactions
- Warfarin and oral anticoagulants: Animal research found that rutin reduced warfarin's anticoagulant effect by 31%, primarily by accelerating the elimination of the more pharmacologically active S-enantiomer of warfarin -- with the elimination half-life of S-warfarin shortened by 37%.7 While this study was conducted in rats, the clinical implication is that rutin may lower anticoagulant effectiveness in individuals on warfarin. Anyone taking warfarin or other vitamin K antagonists should consult their prescribing physician before adding rutin.
- Antiplatelet drugs (aspirin, clopidogrel, NSAIDs): Rutin's own platelet-inhibiting activity may produce additive effects with antiplatelet medications. Monitor for unusual bruising or prolonged bleeding.
- CYP450 substrates: Flavonoids can modulate cytochrome P450 enzyme activity, potentially altering blood levels of co-administered drugs with a narrow therapeutic index. Consult a pharmacist if you take such medications concurrently.
Pregnancy and breastfeeding
Controlled human safety data for rutin during pregnancy and breastfeeding are absent. Until adequate human studies are completed, pregnant and breastfeeding individuals should avoid rutin supplementation unless directed otherwise by a qualified healthcare provider.
Who should use extra caution
- Individuals on anticoagulant or antiplatelet therapy
- People scheduled for surgery (consider discontinuing at least two weeks in advance due to potential effects on platelet function and coagulation)
- Pregnant or breastfeeding individuals
- Those with a personal or family history of bleeding disorders
If you have a medical condition or take prescription medications, consult your healthcare provider before beginning rutin supplementation.
Rutin: Doses Used in Clinical Trials
The following doses reflect amounts used in published human studies. They are not prescriptive recommendations. Individual needs vary, and optimal dosing has not been definitively established.
| Goal | Typical Dose | Timing | Notes |
|---|---|---|---|
| General antioxidant support (healthy adults) | 500 mg/day | With a meal | Used in a 6-week human study; confirmed elevated plasma flavonoid metabolites, but no significant change in antioxidant capacity in already-healthy subjects. |
| Metabolic and blood pressure support (type 2 diabetes) | 1000 mg/day | With a meal | Dose used in a 3-month RCT in T2DM patients; significant improvements in blood pressure and antioxidant enzymes versus placebo. |
| Venous edema and capillary support (as oxerutins) | 1500-2000 mg/day (divided doses) | With meals, divided 2-3 times per day | Doses used in CVI trials. Note: these trials used hydroxyethylrutinoside (oxerutin) derivatives, not standard rutin. Results may not extrapolate directly to unmodified rutin supplements. |
Standard rutin has limited oral bioavailability. Taking it with food may improve absorption. Doses above 2 g/day have not been well studied in humans.
Rutin vs. Quercetin: Key Differences at a Glance
Rutin and quercetin are closely related -- rutin is simply quercetin attached to a two-sugar molecule. Despite this structural similarity, they differ in bioavailability, evidence base, and practical use.
| Feature | Rutin (Quercetin Glycoside) | Quercetin (Aglycone) |
|---|---|---|
| Chemical form | Quercetin bound to rutinose disaccharide (rhamnose + glucose) | Free flavonol; no attached sugar |
| Oral bioavailability | Lower; requires gut bacterial hydrolysis before absorption | Generally higher; multiple enhanced forms (e.g., quercetin phytosome) available |
| Primary human evidence | Venous insufficiency (oxerutin forms); antioxidant support in T2DM and kidney disease | Antioxidant activity; some cardiovascular and metabolic data |
| Strongest clinical evidence | Oxerutin (semi-synthetic derivative) trials in CVI, 212-patient RCT showing 46.8% QoL improvement | More limited RCT data; evidence base growing |
| Typical trial dose | 500-2000 mg/day | 500-1000 mg/day |
| Warfarin interaction | May reduce warfarin efficacy (animal data: 31% reduction in anticoagulant effect) | May increase warfarin effect (inhibits CYP2C9 metabolism) |
| Key dietary sources | Buckwheat, citrus peel, onions, asparagus | Onions, capers, kale, apples, broccoli |
Both compounds share core antioxidant and anti-inflammatory mechanisms. The clinical evidence for rutin's vascular benefits is largely based on its semi-synthetic oxerutin derivatives, not pure rutin.
Frequently Asked Questions
What is Rutin good for?
Rutin is most studied for vascular health, particularly supporting healthy veins and capillary integrity. The strongest human evidence centers on semi-synthetic oxerutin derivatives for reducing leg swelling and improving quality of life in chronic venous insufficiency. A 2023 RCT also found 1 g/day improved blood pressure and antioxidant enzyme levels in people with type 2 diabetes.
How much Rutin should I take per day?
Human trials have used 500 mg to 2000 mg per day. A 2023 randomized trial used 1 g/day for metabolic and antioxidant effects in type 2 diabetes. Venous insufficiency trials typically used 1500-2000 mg/day of oxerutin derivatives. Standard rutin's bioavailability is limited, so taking it with food is advisable. No universal optimal dose has been established.
Is Rutin safe to take daily?
Long-term registry data over five years found no significant adverse changes in blood parameters with up to 2 g/day of hydroxyethylrutosides. Doses up to 2 g/day appear well tolerated in most adults. However, safety has not been established in pregnant or breastfeeding individuals, and rutin interacts with anticoagulant drugs including warfarin.
Does Rutin thin the blood?
Rutin has antiplatelet and anticoagulant properties documented in laboratory research. Importantly, animal research found that rutin reduced warfarin's anticoagulant effect by 31% by accelerating the drug's metabolism -- the opposite of thinning the blood further. Anyone on blood-thinning medications should discuss rutin with their physician before starting.
What foods are naturally high in Rutin?
Buckwheat is among the richest dietary sources of rutin. Other sources include citrus peel and pith, onions and shallots, asparagus, apples, and green or black tea. However, food-based intakes are typically far below the 500-2000 mg/day doses used in clinical studies, making supplementation necessary for studied effects.
Is Rutin the same as quercetin?
No, but they are closely related. Rutin is quercetin bonded to a two-sugar molecule (rutinose), making it a glycoside of quercetin. The body cleaves this sugar in the gut -- primarily via gut bacteria -- to release quercetin for absorption. Rutin has lower and more variable bioavailability than some quercetin forms, but may provide more gradual absorption.
What are the side effects of Rutin?
At doses used in clinical trials (500-2000 mg/day), rutin is generally well tolerated. The most commonly reported adverse effects are mild gastrointestinal symptoms such as nausea and stomach discomfort. Headache and flushing have been occasionally noted. Due to its effects on platelet function and drug metabolism, caution is needed with blood-thinning medications.
Can Rutin help with varicose veins or leg swelling?
Semi-synthetic rutin derivatives called oxerutins (Venoruton, hydroxyethylrutosides) have demonstrated clinical benefits for chronic venous insufficiency, including a 46.8% improvement in quality-of-life scores in a 212-patient RCT. Standard rutin supplements have not been as rigorously tested for varicose veins specifically. Compression therapy remains the primary standard of care for this condition.
Does Rutin interact with warfarin?
Yes, based on animal research, rutin appears to reduce warfarin's anticoagulant effectiveness by accelerating the elimination of S-warfarin (its more active form) -- resulting in a 31% reduction in anticoagulant effect. This interaction has not been confirmed in human trials, but the finding is clinically significant enough that anyone on warfarin or similar anticoagulants should consult their doctor before taking rutin.
What is the difference between Rutin and oxerutins (Venoruton)?
Oxerutins are semi-synthetic derivatives of rutin modified with hydroxyethyl groups to improve water solubility and oral bioavailability. Most clinical trials for chronic venous insufficiency used oxerutins, not pure rutin. The two are related but not equivalent -- extrapolating oxerutin trial results directly to standard rutin supplements requires caution, as bioavailability and clinical effects may differ.
Shop Rutin
HealthFare Rutin supplements
Scientific References
- 1.Bazyar H, Zare Javid A, Ahangarpour A, et al. The effects of rutin supplement on blood pressure markers, some serum antioxidant enzymes, and quality of life in patients with type 2 diabetes mellitus compared with placebo. Frontiers in Nutrition. 2023. PubMed: 37599700Clinical (RCT / meta-analysis)
- 2.Boyle SP, Dobson VL, Duthie SJ, Hinselwood DC, Kyle JA, Collins AR Bioavailability and efficiency of rutin as an antioxidant: a human supplementation study. European Journal of Clinical Nutrition. 2000. PubMed: 11083486Clinical (RCT / meta-analysis)
- 3.Morling JR, Broderick C, Yeoh SE, Kolbach DN Rutosides for treatment of post-thrombotic syndrome. Cochrane Database of Systematic Reviews. 2018. PubMed: 30406640Clinical (RCT / meta-analysis)
- 4.Omar S, El Borolossy RM, Elsaid T, Sabri NA Evaluation of the combination effect of rutin and vitamin C supplementation on the oxidative stress and inflammation in hemodialysis patients. Frontiers in Pharmacology. 2022. PubMed: 36160426Clinical (RCT / meta-analysis)
- 5.Ganeshpurkar A, Saluja AK The Pharmacological Potential of Rutin. Saudi Pharmaceutical Journal. 2017. PubMed: 28344465Preclinical (animal / cell)
- 6.Belcaro G, Cesarone MR, Bavera P, et al. HR (Venoruton1000, Paroven, 0-[beta-hydroxyethyl]-rutosides) vs. Daflon 500 in chronic venous disease and microangiopathy: an independent prospective, controlled, randomized trial. Journal of Cardiovascular Pharmacology and Therapeutics. 2002. PubMed: 12232562Clinical (RCT / meta-analysis)
- 7.Chan E, Hegde A, Chen X Effect of rutin on warfarin anticoagulation and pharmacokinetics of warfarin enantiomers in rats. Journal of Pharmacy and Pharmacology. 2009. PubMed: 19298691Preclinical (animal / cell)
- 8.Cesarone MR, Incandela L, DeSanctis MT, et al. Treatment of edema and increased capillary filtration in venous hypertension with HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides): a clinical, prospective, placebo-controlled, randomized, dose-ranging trial. Journal of Cardiovascular Pharmacology and Therapeutics. 2002. PubMed: 12011969Clinical (RCT / meta-analysis)
- 9.Stuard S, Cesarone MR, Belcaro G, et al. Five-year treatment of chronic venous insufficiency with O-(beta-hydroxyethyl)-rutosides: safety aspects. International Journal of Angiology. 2008. PubMed: 22477419Human observational
- 10.Cesarone MR, Belcaro G, Pellegrini L, et al. Venoruton vs Daflon: evaluation of effects on quality of life in chronic venous insufficiency. Angiology. 2006. PubMed: 16518519Clinical (RCT / meta-analysis)
- 11.Budzynska B, Faggio C, Kruk-Slomka M, et al. Rutin as Neuroprotective Agent: From Bench to Bedside. Current Medicinal Chemistry. 2019. PubMed: 28971760Preclinical (animal / cell)